UBS O'Connor’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-74,950
Closed -$5.75M – 538
2023
Q3
$5.75M Buy
+74,950
New +$6.22M 0.1% 102
2022
Q4
– Sell
-23,941
Closed -$1.7M – 772
2022
Q3
$1.7M Buy
+23,941
New +$2.15M 0.02% 665
2020
Q4
– Sell
-12,500
Closed -$976K – 605
2020
Q3
$976K Buy
+12,500
New +$942K 0.02% 227
2018
Q1
– Sell
-125,471
Closed -$11.6M – 324
2017
Q4
$11.6M Buy
+125,471
New +$11.4M 0.21% 78
2016
Q2
– Sell
-18,843
Closed -$1.36M – 433
2016
Q1
$1.36M Buy
+18,843
New +$1.23M 0.01% 345
2015
Q2
– Sell
-34,390
Closed -$2.38M – 827
2015
Q1
$2.38M Buy
+34,390
New +$2.48M 0.02% 398
2014
Q3
– Sell
-219,643
Closed -$19.2M – 476
2014
Q2
$19.2M Buy
219,643
+53,310
+32% +$4.63M 0.12% 83
2014
Q1
$14.3M Buy
166,333
+31,333
+23% +$2.57M 0.27% 125
2013
Q4
$10.9M Buy
+135,000
New +$10.5M 0.2% 161

Other funds holding EMN

UBS O'Connor's EMN Position: Q4 2023 in Review

UBS O'Connor sold out of Eastman Chemical (EMN) in Q4 2023, closing a stake of 74,950 shares — an estimated $5.75M sold.

UBS O'Connor first reported a position in EMN in Q4 2013 and held it in 9 quarters. The position peaked at $19.2M in Q2 2014. 712 funds tracked by Wall St. Rank hold EMN as of Q4 2023.

  • UBS O'Connor reported no remaining Eastman Chemical position as of Q4 2023 after selling out during the quarter.
  • UBS O'Connor sold 74,950 Eastman Chemical shares in Q4 2023, an estimated $5.75M.
  • UBS O'Connor first reported a position in Eastman Chemical in Q4 2013 and held it in 9 quarters.
  • UBS O'Connor's Eastman Chemical position peaked at $19.2M in Q2 2014.
  • 712 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.